AI-generated summary
This narrative review, written as a tribute to Prof. Crispian Scully, examines evidence from human case reports on low-dose photodynamic therapy and photobiomodulation for oral diseases. The authors report that most reports provide promising evidence of clinical efficacy. They note that inadequate technical details, unclear biological rationale and limited outcome measures restrict the current usefulness of these treatments.
- Who or what was studied
- Patients with oral diseases, as described in human case reports
- Limits stated in the abstract
- The abstract states that the reports lack adequate technical details, precise biological rationale and sufficient outcome measures, and calls for better designed, controlled studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dose, Photobiomodulation therapy, Photodynamic therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.